Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

E. S. Kilpatrick, A. S. Rigby, K. Goode, Stephen Atkin

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

Aims/hypothesis: The main disadvantage of intensive treatment in the Diabetes Control and Complications Trial (DCCT) was an increased risk of hypoglycaemia that was not explained by the difference in HbA1c values alone. This study re-analysed DCCT data to establish whether mean blood glucose (MBG) and/or glucose variability add to the predictive value of HbA 1c for hypoglycaemia risk in type 1 diabetes. Methods: The times to first and subsequent severe hypoglycaemic events were compared with MBG, HbA1c and within-day SD of blood glucose using Cox regression after adjusting for other known risk factors for hypoglycaemia. Results: On its own, the incidence of time to first hypoglycaemic event increased 1.05-fold for each 1 mmol/l decrease in MBG and 1.07-fold for every 1 mmol/l increase in glucose SD. MBG and SD of blood glucose also both added to the ability of HbA 1c to predict repeated hypoglycaemic events: after adjusting for HbA1c, a 1 mmol/l increase in SD was associated with a 1.09-fold increased risk of a first event, increasing to a 1.12-fold risk of a fifth event. A 1 mmol/l fall in MBG added a constant 1.02-1.03-fold risk of repeated events. Daytime events were predicted more accurately than nocturnal episodes. Conclusions/interpretation: This study has established that HbA1c, MBG and glucose variability measurements each have an independent role in determining an individual's risk of hypoglycaemia in type 1 diabetes. All three aspects of glycaemic assessment should thus be considered in patients in whom hypoglycaemia is a real or potential problem.

Original languageEnglish
Pages (from-to)2553-2561
Number of pages9
JournalDiabetologia
Volume50
Issue number12
DOIs
Publication statusPublished - Dec 2007
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Hypoglycemia
Blood Glucose
Glucose
Hypoglycemic Agents
Diabetes Complications
Incidence

Keywords

  • DCCT
  • Diabetes
  • Glucose
  • Glucose variability
  • Glycated haemoglobin
  • HbA
  • Hypoglycaemia

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. / Kilpatrick, E. S.; Rigby, A. S.; Goode, K.; Atkin, Stephen.

In: Diabetologia, Vol. 50, No. 12, 12.2007, p. 2553-2561.

Research output: Contribution to journalArticle

@article{2434fcb3113149e5a76c9b3927327e58,
title = "Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes",
abstract = "Aims/hypothesis: The main disadvantage of intensive treatment in the Diabetes Control and Complications Trial (DCCT) was an increased risk of hypoglycaemia that was not explained by the difference in HbA1c values alone. This study re-analysed DCCT data to establish whether mean blood glucose (MBG) and/or glucose variability add to the predictive value of HbA 1c for hypoglycaemia risk in type 1 diabetes. Methods: The times to first and subsequent severe hypoglycaemic events were compared with MBG, HbA1c and within-day SD of blood glucose using Cox regression after adjusting for other known risk factors for hypoglycaemia. Results: On its own, the incidence of time to first hypoglycaemic event increased 1.05-fold for each 1 mmol/l decrease in MBG and 1.07-fold for every 1 mmol/l increase in glucose SD. MBG and SD of blood glucose also both added to the ability of HbA 1c to predict repeated hypoglycaemic events: after adjusting for HbA1c, a 1 mmol/l increase in SD was associated with a 1.09-fold increased risk of a first event, increasing to a 1.12-fold risk of a fifth event. A 1 mmol/l fall in MBG added a constant 1.02-1.03-fold risk of repeated events. Daytime events were predicted more accurately than nocturnal episodes. Conclusions/interpretation: This study has established that HbA1c, MBG and glucose variability measurements each have an independent role in determining an individual's risk of hypoglycaemia in type 1 diabetes. All three aspects of glycaemic assessment should thus be considered in patients in whom hypoglycaemia is a real or potential problem.",
keywords = "DCCT, Diabetes, Glucose, Glucose variability, Glycated haemoglobin, HbA, Hypoglycaemia",
author = "Kilpatrick, {E. S.} and Rigby, {A. S.} and K. Goode and Stephen Atkin",
year = "2007",
month = "12",
doi = "10.1007/s00125-007-0820-z",
language = "English",
volume = "50",
pages = "2553--2561",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

AU - Kilpatrick, E. S.

AU - Rigby, A. S.

AU - Goode, K.

AU - Atkin, Stephen

PY - 2007/12

Y1 - 2007/12

N2 - Aims/hypothesis: The main disadvantage of intensive treatment in the Diabetes Control and Complications Trial (DCCT) was an increased risk of hypoglycaemia that was not explained by the difference in HbA1c values alone. This study re-analysed DCCT data to establish whether mean blood glucose (MBG) and/or glucose variability add to the predictive value of HbA 1c for hypoglycaemia risk in type 1 diabetes. Methods: The times to first and subsequent severe hypoglycaemic events were compared with MBG, HbA1c and within-day SD of blood glucose using Cox regression after adjusting for other known risk factors for hypoglycaemia. Results: On its own, the incidence of time to first hypoglycaemic event increased 1.05-fold for each 1 mmol/l decrease in MBG and 1.07-fold for every 1 mmol/l increase in glucose SD. MBG and SD of blood glucose also both added to the ability of HbA 1c to predict repeated hypoglycaemic events: after adjusting for HbA1c, a 1 mmol/l increase in SD was associated with a 1.09-fold increased risk of a first event, increasing to a 1.12-fold risk of a fifth event. A 1 mmol/l fall in MBG added a constant 1.02-1.03-fold risk of repeated events. Daytime events were predicted more accurately than nocturnal episodes. Conclusions/interpretation: This study has established that HbA1c, MBG and glucose variability measurements each have an independent role in determining an individual's risk of hypoglycaemia in type 1 diabetes. All three aspects of glycaemic assessment should thus be considered in patients in whom hypoglycaemia is a real or potential problem.

AB - Aims/hypothesis: The main disadvantage of intensive treatment in the Diabetes Control and Complications Trial (DCCT) was an increased risk of hypoglycaemia that was not explained by the difference in HbA1c values alone. This study re-analysed DCCT data to establish whether mean blood glucose (MBG) and/or glucose variability add to the predictive value of HbA 1c for hypoglycaemia risk in type 1 diabetes. Methods: The times to first and subsequent severe hypoglycaemic events were compared with MBG, HbA1c and within-day SD of blood glucose using Cox regression after adjusting for other known risk factors for hypoglycaemia. Results: On its own, the incidence of time to first hypoglycaemic event increased 1.05-fold for each 1 mmol/l decrease in MBG and 1.07-fold for every 1 mmol/l increase in glucose SD. MBG and SD of blood glucose also both added to the ability of HbA 1c to predict repeated hypoglycaemic events: after adjusting for HbA1c, a 1 mmol/l increase in SD was associated with a 1.09-fold increased risk of a first event, increasing to a 1.12-fold risk of a fifth event. A 1 mmol/l fall in MBG added a constant 1.02-1.03-fold risk of repeated events. Daytime events were predicted more accurately than nocturnal episodes. Conclusions/interpretation: This study has established that HbA1c, MBG and glucose variability measurements each have an independent role in determining an individual's risk of hypoglycaemia in type 1 diabetes. All three aspects of glycaemic assessment should thus be considered in patients in whom hypoglycaemia is a real or potential problem.

KW - DCCT

KW - Diabetes

KW - Glucose

KW - Glucose variability

KW - Glycated haemoglobin

KW - HbA

KW - Hypoglycaemia

UR - http://www.scopus.com/inward/record.url?scp=35848934997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848934997&partnerID=8YFLogxK

U2 - 10.1007/s00125-007-0820-z

DO - 10.1007/s00125-007-0820-z

M3 - Article

VL - 50

SP - 2553

EP - 2561

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 12

ER -